Mega Lifesciences Public Company Limited Cash Flow Conversion Efficiency
Mega Lifesciences Public Company Limited cash flow conversion efficiency. Based on the latest financial reports, Mega Lifesciences Public Company Limited (MEGA) has a cash flow conversion efficiency ratio of 0.017x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (฿173.01 Million ≈ $5.39 Million USD) by net assets (฿10.34 Billion ≈ $322.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Mega Lifesciences Public Company Limited (2011–2025)
Cash flow conversion efficiency of Mega Lifesciences Public Company Limited from 2011 to 2025. This chart illustrates how Mega Lifesciences Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MEGA share price today for real-time trading data and today's change.
Mega Lifesciences Public Company Limited Cash Flow Conversion Ratio Explained
Mega Lifesciences Public Company Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Mega Lifesciences Public Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mega Lifesciences Public Company Limited ranked by their cash flow conversion efficiency. Also see how much is Mega Lifesciences Public Company Limited worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sabine Royalty Trust
NYSE:SBR
|
10.650x |
|
Rio Tinto PLC
LSE:RIO
|
0.112x |
|
Jade Biosciences, Inc.
NASDAQ:JBIO
|
-0.099x |
|
Jiangsu Dagang Co Ltd
SHE:002077
|
0.016x |
|
Marten Transport Ltd
NASDAQ:MRTN
|
0.036x |
|
Rastar Environmental Protection Materials Co.Ltd.
SHE:300834
|
0.021x |
|
Seegene Inc
KQ:096530
|
0.035x |
|
INVENTIVA ADS/1 O.N.
F:6IVA
|
N/A |
Annual Cash Flow Conversion Efficiency for Mega Lifesciences Public Company Limited (2011–2025)
The table below shows the annual cash flow conversion efficiency of Mega Lifesciences Public Company Limited from 2011 to 2025. Review MEGA free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ฿10.22 Billion ≈ $318.40 Million |
฿2.81 Billion ≈ $87.50 Million |
0.275x | +13.02% |
| 2024-12-31 | ฿9.88 Billion ≈ $307.85 Million |
฿2.40 Billion ≈ $74.85 Million |
0.243x | +17.40% |
| 2023-12-31 | ฿9.30 Billion ≈ $289.94 Million |
฿1.93 Billion ≈ $60.05 Million |
0.207x | -8.96% |
| 2022-12-31 | ฿8.78 Billion ≈ $273.56 Million |
฿2.00 Billion ≈ $62.23 Million |
0.227x | -33.05% |
| 2021-12-31 | ฿8.03 Billion ≈ $250.14 Million |
฿2.73 Billion ≈ $84.99 Million |
0.340x | +45.53% |
| 2020-12-31 | ฿6.98 Billion ≈ $217.53 Million |
฿1.63 Billion ≈ $50.79 Million |
0.233x | -3.57% |
| 2019-12-31 | ฿6.18 Billion ≈ $192.47 Million |
฿1.50 Billion ≈ $46.60 Million |
0.242x | +50.75% |
| 2018-12-31 | ฿5.72 Billion ≈ $178.42 Million |
฿919.36 Million ≈ $28.66 Million |
0.161x | -9.14% |
| 2017-12-31 | ฿5.24 Billion ≈ $163.46 Million |
฿927.00 Million ≈ $28.89 Million |
0.177x | -34.37% |
| 2016-12-31 | ฿4.68 Billion ≈ $145.87 Million |
฿1.26 Billion ≈ $39.29 Million |
0.269x | +91.67% |
| 2015-12-31 | ฿4.33 Billion ≈ $135.11 Million |
฿609.12 Million ≈ $18.99 Million |
0.141x | -8.98% |
| 2014-12-31 | ฿3.98 Billion ≈ $124.00 Million |
฿614.22 Million ≈ $19.14 Million |
0.154x | +22.40% |
| 2013-12-31 | ฿3.69 Billion ≈ $115.09 Million |
฿465.77 Million ≈ $14.52 Million |
0.126x | -40.02% |
| 2012-12-31 | ฿1.63 Billion ≈ $50.69 Million |
฿342.02 Million ≈ $10.66 Million |
0.210x | +3.97% |
| 2011-12-31 | ฿1.32 Billion ≈ $41.09 Million |
฿266.67 Million ≈ $8.31 Million |
0.202x | -- |
About Mega Lifesciences Public Company Limited
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, includi… Read more